Methods of treating necrotizing enterocolitis

Details Methods of treating necrotizing enterocolitis Methods of treating necrotizing enterocolitis

2011-07-19

2011-07-19

Richter, Johann R (Department: 1616)

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

Carbon disulfide, monoxide, or dioxide

Reexamination Certificate

active

07981448

ABSTRACT:
The present invention relates to a method of treating necrotizing enterocolitis in a patient, which includes administering a pharmaceutical composition that includes carbon monoxide to the patient.

REFERENCES:
patent: 4053590 (1977-10-01), Bonsen et al.
patent: 4264739 (1981-04-01), Grabner et al.
patent: 4923817 (1990-05-01), Mundt
patent: 5084380 (1992-01-01), Carney
patent: 5180366 (1993-01-01), Woods
patent: 5240912 (1993-08-01), Todaro
patent: 5293875 (1994-03-01), Stone
patent: 5449665 (1995-09-01), Sollevi
patent: 5476764 (1995-12-01), Bitensky
patent: 5498421 (1996-03-01), Grinstaff et al.
patent: 5632162 (1997-05-01), Billy
patent: 5664563 (1997-09-01), Schroeder et al.
patent: 5731326 (1998-03-01), Hart et al.
patent: 5763431 (1998-06-01), Jackson
patent: 5792325 (1998-08-01), Richardson, Jr.
patent: 5882674 (1999-03-01), Herrmann et al.
patent: 5885621 (1999-03-01), Head et al.
patent: 5914316 (1999-06-01), Brown et al.
patent: 6066333 (2000-05-01), Willis et al.
patent: 6069132 (2000-05-01), Revanker et al.
patent: 6203991 (2001-03-01), Nabel et al.
patent: 6313144 (2001-11-01), McCullough et al.
patent: 6316403 (2001-11-01), Pinsky et al.
patent: 7045140 (2006-05-01), Motterlini et al.
patent: 7238469 (2007-07-01), Bach et al.
patent: 7364757 (2008-04-01), Otterbein et al.
patent: 7678390 (2010-03-01), Choi et al.
patent: 7687079 (2010-03-01), Otterbein et al.
patent: 7691416 (2010-04-01), Otterbein et al.
patent: 2002/0155166 (2002-10-01), Choi et al.
patent: 2003/0009127 (2003-01-01), Trescony et al.
patent: 2003/0039638 (2003-02-01), Bach et al.
patent: 2003/0064114 (2003-04-01), Motterlini et al.
patent: 2003/0068387 (2003-04-01), Buelow et al.
patent: 2003/0219496 (2003-11-01), Otterbein et al.
patent: 2003/0219497 (2003-11-01), Otterbein et al.
patent: 2004/0052866 (2004-03-01), Otterbein et al.
patent: 2004/0067261 (2004-04-01), Haas et al.
patent: 2004/0131703 (2004-07-01), Bach et al.
patent: 2004/0197271 (2004-10-01), Kunka et al.
patent: 2004/0228930 (2004-11-01), Billiar et al.
patent: 2004/0258772 (2004-12-01), Otterbein et al.
patent: 2005/0048133 (2005-03-01), Pinsky et al.
patent: 2005/0215468 (2005-09-01), Bar-Or et al.
patent: 2005/0250688 (2005-11-01), Pinsky et al.
patent: 2005/0255178 (2005-11-01), Bloch et al.
patent: 2006/0003922 (2006-01-01), Bach et al.
patent: 2007/0202083 (2007-08-01), Bach et al.
patent: 2 816 212 (2002-05-01), None
patent: 56079957 (1981-06-01), None
patent: WO 94/22482 (1994-10-01), None
patent: WO 95/35105 (1995-12-01), None
patent: WO 98/08523 (1998-03-01), None
patent: WO 98/13058 (1998-04-01), None
patent: WO 99/49880 (1999-04-01), None
patent: WO 99/47512 (1999-09-01), None
patent: WO 02/09731 (2002-02-01), None
patent: WO 02/078684 (2002-10-01), None
patent: WO 02/092075 (2002-11-01), None
patent: WO 03/000114 (2003-01-01), None
patent: WO 03/066067 (2003-08-01), None
patent: WO 03/072024 (2003-09-01), None
patent: WO 03/088923 (2003-10-01), None
patent: WO 03/088981 (2003-10-01), None
patent: WO 03/094932 (2003-11-01), None
patent: WO 03/096977 (2003-11-01), None
patent: WO 03/103585 (2003-12-01), None
patent: WO 04/000368 (2003-12-01), None
patent: WO 2004/004817 (2004-01-01), None
patent: WO 2004/043341 (2004-05-01), None
Verran et al, Use of liver allografts from carbon monoxide poisoned carveric dononrs, Transplantation, vol. 62, No. 10, pp. 1514-1515.
Wing-Gaia et al., International Journal of Sport Nutrition and Exercise Metabolism (2005), vol. 15, pp. 680-688.
Verran et al., Use of liver allografts from carbon monoxide poisoned cadaveric donors, Transplantation (1996), vol. 62, No. 10, pp. 1514, 1515.
Abidin et al., “The Combined Effect of Carbon Monoxide and Normobaric Hyperoxia on Animals”, Kosmicheskaya Biologiya I Aviakosmicheskaya Meditsina 6: 63-67 (1978).
Arita et al., “Prevention of Primary Islet Isograft Nonfunction in Mice with Pravastatin,”Transplantation65:1429-33 (1998).
Arnush et al., “IL-1 Produced and Released Endogenously within Human Islets Inhibits β Cell Function,” J. Clin Invest. 102:516-26 (1998).
Bach et al., “Accommodation of vascularized xenografts: Expression of “protective genes” by donor endothelial cells in a host Th2 cytokine environment,”Nature Med.3:196-204 (1997).
Berney et al., “Islet cell transplantation: the future?”Langenbeck's Arch. Surg.385: 373-8 (2000).
Bentley et al., “Successful Cardiac Transplantation with Methanol or Carbon Monoxide-Poisoned Donors,”Thorac Surg71(4):1194-7 (2001).
Brouard et al., “Carbon Monoxide Generated by Heme Oxygenase-1 Suppresses Endothelial Cell Apoptosis,”J Exp Med192(7):1015-25 (2000).
Brown et al., “In vivo binding of carbon monoxide to cytochromecoxidase in rat brain”, American Physiological Society, pp. 604-610 (1990).
Campbell, “Living At Very High Altitudes”,The Lancet1:370-373 (1930).
Campbell, “The Effect of Carbon Monoxide and Other Agents Upon the Rate of Tumour Growth”, J Pathology & Bacteriology 35:379-394 (1932).
Campell, “Cancer of Skin and Increase in Incidence of Primary Tumours of Lung in Mice Exposed to Dust Obtained from Tarred Roads”,Brit. J Exper. Pathol.XV(5):24, 289-294 (1934).
Cantrell et al., “Low-Dose Carbon Monoxide Does Not Reduce Vasoconstriction in Isolated Rat Lungs”,Experimental Lung Research22:21-32 (1996).
Cardell et al., “Bronchondilatation in vivo by carbon monoxide, a cyclic GMP related messenger”, British J. of Pharmacology 124:1065-1068 (1998).
Carlsson et al., “Measurements of Oxygen Tension in Native and Transplanted Rat Pancreatic Islets,”Diabetes47:1027-32 (1998).
Carraway et al., “Induction of ferritin and heme oxygenase-1 by endotoxin in the lung”,Am J Physiol Lung Cell Mol Physiol275:L583-592 (1998).
Cecil Textbook of Medicine (21stEd. 2000) 1:273-279, 357-372, 387-419, 425-427, 436-448, 466-475, 507-512, 1060-1074.
Cecil Textbook of Medicine (21stEd. 2000) 2:1492-1499, 2042-2047, 2079-2081.
Chapman et al., “Exogenous Carbon Monoxide Attenuates Aeroallergen-induced Eosinophilic Inflammation in Mice”,J Respiratory Critical Care Med159(3):A218 (1999).
Chapman et al., “Carbon Monoxide Attenuates Aeroallergen-induced Inflammation in Mice”,Am. J. Physiol. Lung Cell Mol Physiol.281:L209-L216 (2001).
Choi et al., “Heme Oxygenase-1: Function, Regulation, and Implication of a Novel Stress-inducible Protein in Oxidant-induced Lung Injury”,Am. J. Respir. Cell Mol. Biol.15:9-19 (1996).
Christodoulides et al., “Vascular Smooth Muscle Cell Heme Oxygenases Generate Guanylyl Cyclase-Stimulatory Carbon Monoxide,”Circulation97:2306-9 (1995).
Corbett et al., “Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans,”Proc. Natl. Acad. Sci USA90:1731-5 (1993).
Davidson et al., “Inflammatory Modulation and Wound Repair”J Investigative Dermatologyxi-xii (2003).
Dioum et al., “NPAS2: A Gas-Responsive Transcription Factor”, Sciencexpress/www.sciencexpress.org/21 November 2002/pages 1-6/10.1126/science.1078456.
Donnelly et al., “Expression of Heme-Oxygenase in Human Airway Primary Epithelial Cells”,J Respiratory Critical Care Med159(3):A218 (1999).
Friebe et al., “YC-1 Potentiates Nitic Oxide- and Carbon Monoxide-Induced Cyclic GMP Effects in Human Platelets”, Molecular Pharmacology 54: 962-967 (1998).
Gaine et al., “Induction of Heme Oxygenase-1 with Hemoglobin Depresses Vasoreactivity in Rat Aorta,”J Vasc Res36(2):114-9 (1999).
Grau et al., “Influence of Carboxyhemoglobin Level on Tumor Growth, Blood Flow, and Radiation Response in an Experimental Model,”Int. J. Radiation Oncology Biol. Phys.22:421-424 (1992).
Grau et al., “Effect of Carbon Monoxide Breathing on Hypoxia and Radiation Response in the SCCVII Tumor in vivo”,Int. J. Radiation Oncology Biol. Phys.29:449-454 (199

Affiliated with

Also associated with

Rating

Methods of treating necrotizing enterocolitis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating necrotizing enterocolitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating necrotizing enterocolitis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2658806